Difinsa53

Difinsa53 · ProTechSure Scientific, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Difinsa53, covering 2017-10-06 to 2017-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Topical Use of Difinsa53™ to Prevent Radiation Dermatitis [Phase 1, Phase 2]